Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority trialResearch in context

• Main Authors: Inge J.M.H. Caelers (Author), Ruud Droeghaag (Author), Suzanne L. de Kunder (Author), Jasper Most (Author), Kim Rijkers (Author), Ronald H.M.A. Bartels (Author), Jos M.A. Kuijlen (Author), Mark H.H.M. Hulsbosch (Author), Wouter L.W. van Hemert (Author), Rob A. de Bie (Author), Henk van Santbrink (Author)
• Format: Book
• Published: Elsevier, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: The effectiveness of transforaminal lumbar interbody fusion (TLIF) compared to posterior lumbar interbody fusion (PLIF) in patients with single-level spondylolisthesis has not been substantiated. To address the evidence gap, a well-powered randomized controlled non-inferiority t...